drugset / Trial / NCT03857425

Helicobacter Pylori Eradication With Clostridum Butyricum Capsule and Bacillus Coagulans Tablets

NCT03857425

Phase 4 Completed 150 enrolled Xijing Hospital of Digestive Diseases
RandomizedParallel-groupOpen-labelTreatment

Summary

This study aims at evaluating efficacy Clostridum Butyricum Capsule and Bacillus Coagulans Tablets in H. pylori eradication. It is hypothesized that Clostridum Butyricum Capsule , Bacillus Coagulans Tablets monotherapy or Clostridum Butyricum Capsule plus Bacillus Coagulans may have some positive effect on H. pylori eradication.

Timeline

Start
2019-03-01
Primary completion
2019-08-31
Completion
2019-09-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Bacillus coagulans Other / unclassified 350 mg
Subject Clostridium butyricum Other / unclassified 420 mg